Last updated: April 6, 2023
Sponsor: Medical University Innsbruck
Overall Status: Active - Recruiting
Phase
N/A
Condition
Covid-19
Treatment
N/AClinical Study ID
NCT05802875
Building resilience
Ages 18-70 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- GSI-T score (Mini-SCL) ≥63,
- BRS score <3,
- fluent German speakers,
- written informed consent.
Exclusion
Exclusion Criteria:
- Any psychiatric disorder according to the Diagnostic and Statistical Manual of MentalDisorders (DSM-5) (verified by Mini International Neuropsychiatric Interview [M.I.N.I.] 7.0.2), a history of nicotine or caffeine dependence is acceptable,
- currently engaged in any form of regular psychological therapy offered bypsychologists and/or psychiatrists,
- currently engaged in any form of (group) interventions from other disciplines (socialwork, pedagogy, coaching, alternative therapy etc.)
Study Design
Total Participants: 192
Study Start date:
April 01, 2022
Estimated Completion Date:
January 31, 2026
Study Description
Connect with a study center
Medical University Innsbruck
Innsbruck, Tirol 6020
AustriaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.